Leishmaniasis remains a significant public health problem in Brazil, particularly due to , which is associated with severe dermatological syndromes. The current treatments are limited by toxicity and uncertain efficacy, highlighting the need for new compounds with pharmacological potential. This study investigates chalcones as multitarget binding agents for oligopeptidase B (OPB) and cysteine proteinase B (CPB), which are critical pathogenic determinants of . The methodology involved replacing methoxy groups with aryl motifs at various positions within the chalcone structures and introducing specific functional groups at the C-4 position. This was followed by a virtual screening approach using molecular docking to assess interactions with the target proteinases. Several chalcones from the virtual library ( = 178) exhibited high binding affinities for OPB and CPB, outperforming control ligands. A total of 30 chalcones with multitarget potential were identified, with fluorinated compounds C-191 and C-135 emerging as promising inhibitors, distinguished by the best energy rankings for both enzymes. ADMET analyses confirmed the viability of these chalcones as drug candidates, with most adhering to Lipinski's rules. These data suggest that chalcones may provide new multitarget treatment options for leishmaniasis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3390/ijms26052025 | DOI Listing |
J Clin Aesthet Dermatol
February 2025
Dr. Nestor is with the Center for Clinical and Cosmetic Research in Aventura, Florida, the Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine Miami in Miami, Florida, and the Department of Surgery, Division of Plastic Surgery, at the University of Miami Miller School of Medicine Miami, in Miami, Florida.
Objective: The environmental impact of the practice of medicine, including dermatology, can be significant, driven by a growing and aging population that increasingly demands medical resources. This review explores the environmental effects of the practice of dermatology and identifies actionable solutions to reduce negative environmental impacts.
Methods: A PubMed search was conducted using the terms ("environmental impact" OR "sustainability") AND "dermatology.
Research (Wash D C)
March 2025
The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121012, China.
The metaverse enables immersive virtual healthcare environments, presenting opportunities for enhanced care delivery. A key challenge lies in effectively combining multimodal healthcare data and generative artificial intelligence abilities within metaverse-based healthcare applications, which is a problem that needs to be addressed. This paper proposes a novel multimodal learning framework for metaverse healthcare, MMLMH, based on collaborative intra- and intersample representation and adaptive fusion.
View Article and Find Full Text PDFFront Pharmacol
February 2025
Department of Pharmacy, Taizhou School of Clinical Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China.
Concurrent inhibition of bromodomain-containing protein 4 ( signal transductor and activator of transcription 3 (STAT3) could potentially be an effective strategy against renal cell carcinoma (RCC). Here, we successfully identified five dual-targeted BRD4/STAT3 inhibitors (BSTs 1-5) using a combinatorial screening protocol. Particularly, BST-4 was the most potent inhibitor simultaneously targeting BRD4 (IC = 2.
View Article and Find Full Text PDFChem Biol Drug Des
March 2025
School of Pharmacy, Jiangsu Ocean University, Lianyungang, Jiangsu, China.
The bacterial cell wall is crucial for maintaining the integrity of bacterial cells. UDP-N-acetylglucosamine 1-carboxyethylene transferase (MurA) is an important enzyme involved in bacterial cell wall synthesis. Therefore, it is an important target for antibacterial drug research.
View Article and Find Full Text PDFInt J Mol Sci
February 2025
Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy.
Sphingolipidoses, a subgroup of lysosomal storage diseases (LSDs), are rare and debilitating disorders caused by defects in sphingolipid metabolism. Despite advancements in treatment, therapeutic options remain limited. Miglustat, a glucosylceramide synthase EC 2.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!